title: Expression of oligodendroglial differentiation markers in pilocytic astrocytomas identifies two clinical subsets and shows a significant correlation with proliferation index and progression free survival.
abstract: The growth pattern of pilocytic astrocytoma (PAs) is unpredictable. Gene expression profiling has recently demonstrated an inverse relationship between myelin basic protein (MBP) expression and progression free survival (PFS) in PAs. We present here the pattern of expression of oligodendroglial differentiation markers (ODMs) in PAs by immunohistochemistry and their correlation with PI and PFS. Sixty-four cases of PA were reviewed and representative sections were stained for Ki-67 and ODMs, including MBP, platelet-derived growth factor receptor-alpha (PDGFR-alpha), Olig-1, and Olig-2. Sections were graded semi-quantitatively for intensity (I: 0-3+) and extent (E: 0-4+) of staining. PI was expressed as a percentage of Ki-67 positive cells. Immunoreactivity of MBP, PDGFR-alpha, Olig-1, and Olig-2 was observed in 84, 56, 97, and 75% of cases, respectively. There was a statistically significant inverse correlation between MBP expression and PI (r (2) = .696, p = .014). A positive correlation was observed between PDGFR-alpha and PI (r (2) = .727, p = .011). Further analysis showed a significant difference in PFS between low expressors [I + E score < or = 3] and high expressors (I + E score > or = 4) for PDGFR-alpha with p < .001. Notably, there was a significant difference in PFS between high expressors of MBP and high expressors of PDGFR-alpha with p < .001. These results suggest that expression of ODMs, especially MBP and PDGFR-alpha, may identify two clinical subsets of PA. In addition, we have shown the expression of 4 different ODMs in PAs, which may support the possibility that PAs arise from oligodendrocyte progenitor/precursor cells probably similar to the O2A progenitor cells in the mouse.
authors: Department of Pathology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA. takei327@aol.com
authors: Hidehiro
authors: H
authors: Takei
authors: Subashini T
authors: ST
authors: Yogeswaren
authors: Kwong-Kwok
authors: KK
authors: Wong
authors: Vidya
authors: V
authors: Mehta
authors: Murali
authors: M
authors: Chintagumpala
authors: Robert C
authors: RC
authors: Dauser
authors: Ching C
authors: CC
authors: Lau
authors: Adekunle M
authors: AM
authors: Adesina
mesh_terms: D000293:Adolescent; D000328:Adult; D000943:Antigens, Differentiation / Q000378:metabolism*; D001254:Astrocytoma / Q000145:classification / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D051792:Basic Helix-Loop-Helix Proteins / Q000378:metabolism; D014408:Biomarkers, Tumor / Q000378:metabolism*; D001932:Brain Neoplasms / Q000145:classification / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D002454:Cell Differentiation; D002648:Child; D002675:Child, Preschool; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology; D006801:Humans; D007150:Immunohistochemistry; D007223:Infant; D019394:Ki-67 Antigen / Q000378:metabolism; D008297:Male; D004676:Myelin Basic Protein / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000378:metabolism; D000076104:Oligodendrocyte Transcription Factor 2; D009836:Oligodendroglia / Q000378:metabolism*; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000378:metabolism; D012189:Retrospective Studies; D016019:Survival Analysis
chemical_list: D000943:Antigens, Differentiation; D051792:Basic Helix-Loop-Helix Proteins; D014408:Biomarkers, Tumor; D019394:Ki-67 Antigen; D004676:Myelin Basic Protein; D009419:Nerve Tissue Proteins; D000076104:Oligodendrocyte Transcription Factor 2; D020796:Receptor, Platelet-Derived Growth Factor alpha; C405707:OLIG1 protein, human; C405708:OLIG2 protein, human
references: Glycoconj J. 1996 Jun;13(3):433-43
references: 8781974
references: Nature. 1983 Jun 2-8;303(5916):390-6
references: 6304520
references: J Neurol Sci. 1988 Feb;83(2-3):219-25
references: 2451711
references: Acta Neurochir (Wien). 2004 Jun;146(6):581-8; discussion 588
references: 15168226
references: Mol Cell Neurosci. 1997;8(5):311-22
references: 9073394
references: EMBO J. 1989 Apr;8(4):1049-56
references: 2545439
references: Cell. 1988 Apr 22;53(2):309-19
references: 2834067
references: J Neurooncol. 1998 Mar;37(1):9-16
references: 9525833
references: Cancer Lett. 2006 Feb 8;232(2):139-47
references: 16139423
references: J Neurooncol. 2002 Jun;58(2):141-6
references: 12164686
references: Neurosurgery. 2004 Jan;54(1):72-9; discussion 79-80
references: 14683543
references: Hum Pathol. 1998 Dec;29(12):1511-6
references: 9865840
references: J Clin Oncol. 2003 Aug 1;21(15):2968-73
references: 12885817
references: Neurosurgery. 2003 Sep;53(3):544-53; discussion 554-5
references: 12943571
references: J Neuropathol Exp Neurol. 2003 Oct;62(10):1052-9
references: 14575240
references: J Neurooncol. 2006 Sep;79(2):197-201
references: 16598421
references: Childs Nerv Syst. 2005 Jun;21(6):477-81
references: 15378329
references: J Surg Oncol. 2004 Apr 1;86(1):34-40
references: 15048678
references: Cancer Res. 2005 Jan 1;65(1):76-84
references: 15665281
references: J Clin Oncol. 1997 Aug;15(8):2792-9
references: 9256121
references: Neuron. 2000 Feb;25(2):317-29
references: 10719888
references: Microsc Res Tech. 2001 Mar 15;52(6):746-52
references: 11276127
references: Am J Pathol. 1999 Oct;155(4):1261-9
references: 10514408
references: J Cell Biol. 1989 Dec;109(6 Pt 2):3411-7
references: 2557355
references: Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10361-6
references: 10468613
references: Neuropathol Appl Neurobiol. 1999 Apr;25(2):134-42
references: 10216001